Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
TechGuru's Profile
Displaying 301-350 of 1387 result(s).
CYDY CytoDyn Inc
11/06/2020 3:09:26 PM
But with 70% reduction in deaths, w (7)
CYDY CytoDyn Inc
11/01/2020 12:17:13 PM
This is from a couple of days back: (15)
CYDY CytoDyn Inc
11/01/2020 12:07:36 PM
Expharmer, Please check PM. TechGur
CYDY CytoDyn Inc
10/30/2020 9:49:14 AM
Nicehedges, Thank you. Have been wa (2)
CYDY CytoDyn Inc
10/27/2020 9:07:00 AM
For me the real importance of the M (18)
CYDY CytoDyn Inc
10/26/2020 5:14:41 PM
SAF, The evidence will show up. One (1)
CYDY CytoDyn Inc
10/26/2020 4:58:00 PM
While investigators initially didn' (2)
CYDY CytoDyn Inc
10/25/2020 3:43:40 PM
Something we seem to have forgotten (20)
CYDY CytoDyn Inc
10/25/2020 11:34:13 AM
Havasu, Trying to answer your quest (4)
CYDY CytoDyn Inc
10/25/2020 10:32:50 AM
Ohm, My Post-hoc power calculation (3)
CYDY CytoDyn Inc
10/25/2020 10:08:42 AM
Blafarm, Thanks for your feedback. (7)
CYDY CytoDyn Inc
10/24/2020 2:37:43 PM
Good morning to you all. Have been (24)
CYDY CytoDyn Inc
10/23/2020 5:21:34 PM
Nicehedges, Thanks for posting this (2)
CYDY CytoDyn Inc
10/23/2020 2:16:33 PM
The Remdesivir approval speaks volu (18)
CYDY CytoDyn Inc
10/22/2020 9:47:42 AM
KenShowder, In my case, these are n (2)
CYDY CytoDyn Inc
10/22/2020 9:04:45 AM
SeeWhyDY, This is is why are a comp (14)
CYDY CytoDyn Inc
10/21/2020 6:24:08 PM
Faucci (NIH) pushed GILD https://ww
CYDY CytoDyn Inc
10/21/2020 3:09:07 PM
As some of you have already stated (16)
CYDY CytoDyn Inc
10/20/2020 8:48:25 AM
This is a very interesting question (2)
CYDY CytoDyn Inc
10/20/2020 8:37:04 AM
So, this is the news we were expect (24)
CYDY CytoDyn Inc
10/19/2020 12:20:59 PM
Nmbr1stckpckr, I respectfully disag (10)
CYDY CytoDyn Inc
10/19/2020 8:24:59 AM
Some food for thought. Out trial is (10)
CYDY CytoDyn Inc
10/19/2020 7:41:45 AM
If Dr. Patterson wants leronlimab f (4)
CYDY CytoDyn Inc
10/18/2020 7:58:45 AM
Ohm, Thanks for the valuable inform (2)
CYDY CytoDyn Inc
10/17/2020 2:34:08 PM
Maybe has been posted here before ? (4)
CYDY CytoDyn Inc
10/17/2020 2:23:10 PM
Cassandra, Help with full enrollmen (8)
CYDY CytoDyn Inc
10/17/2020 12:38:47 PM
Ohm, Yes. This is precisely what is (7)
CYDY CytoDyn Inc
10/17/2020 10:01:52 AM
This was posted here before. NIH be (7)
CYDY CytoDyn Inc
10/17/2020 9:11:21 AM
Absolutely. This will be achieved w (4)
CYDY CytoDyn Inc
10/17/2020 7:25:08 AM
Ohm, Dr. Hahn's comment on the gold (7)
CYDY CytoDyn Inc
10/16/2020 2:33:52 PM
Dr. Acula, Gilead was the first to
CYDY CytoDyn Inc
10/16/2020 11:30:38 AM
I have been an investor in CYDY for (19)
CYDY CytoDyn Inc
10/15/2020 10:10:24 PM
These are our CD-12 trial measures: (8)
CYDY CytoDyn Inc
10/13/2020 10:04:37 AM
Onestepahead, I would imagine that (2)
CYDY CytoDyn Inc
10/13/2020 9:34:57 AM
Respert, Good point as we are now i (6)
CYDY CytoDyn Inc
10/13/2020 8:55:43 AM
To register leronlimab (PRO 140) fo (2)
CYDY CytoDyn Inc
10/12/2020 8:19:59 AM
I mentioned this before, but this i (10)
CYDY CytoDyn Inc
10/08/2020 12:14:45 PM
CDiddy, Yes. You are right, is in f (1)
CYDY CytoDyn Inc
10/08/2020 10:41:19 AM
PatientLong, I think you could say (3)
CYDY CytoDyn Inc
10/08/2020 8:28:44 AM
Interesting discussion on p-values. (12)
CYDY CytoDyn Inc
10/08/2020 7:50:50 AM
JLang, Give to Caesar what belongs (2)
CYDY CytoDyn Inc
10/07/2020 5:24:51 PM
JLang, NP mentioned in the intervie (4)
CYDY CytoDyn Inc
10/07/2020 3:20:06 PM
Nader did what a good CEO should ha (24)
CYDY CytoDyn Inc
10/07/2020 11:16:33 AM
CDiddy, Not only that. The safety b (5)
CYDY CytoDyn Inc
10/07/2020 9:08:45 AM
I meet you guys in a beach in Thail (6)
CYDY CytoDyn Inc
10/07/2020 8:40:04 AM
Cycl2R, Trials for definition have (7)
CYDY CytoDyn Inc
10/07/2020 8:31:55 AM
DaveEL, Good work. Your numbers are (5)
CYDY CytoDyn Inc
10/06/2020 6:11:28 PM
Dvb, In cases where there are two g (9)
CYDY CytoDyn Inc
10/06/2020 7:46:27 AM
As we anxiously await the results f (22)
CYDY CytoDyn Inc
10/04/2020 11:44:17 AM
MD Virologist, Looking forward to r
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • OpenAI's Plans for $1 Trillion IPO Amid Rising AI Demand
  • Ad Council Welcomes New Leaders to Its Board of Directors
  • InnoCare's Latest Research on Zurletrectinib Unveiled
  • MarketWise, Inc. Receives Acquisition Proposal for Equity Interests
  • ReTo Eco-Solutions Implements Share Combination Strategy
  • Ooredoo and Aduna: Innovating Telecom APIs for Global Reach
  • Introducing Credit Hero Club: Enhancing Financial Transparency in Asia
  • Cambium Networks Stock Soars After Starlink Integration News
  • Trump Memecoin Gains Momentum Amid Cryptocurrency Market Shift
  • M2 Compliance Experiences Unprecedented Growth in 2025
  • AI Adoption in Asia Pacific: Navigating Opportunities and Challenges
  • Unilumin's Role in the Award-Winning China Pavilion at Expo 2025
  • Exciting Developments in RNA Therapeutics: Wave Life Sciences' Progress
  • A Decade of Luxury: The Reverie Saigon’s Remarkable Journey
  • Hurricane Melissa: GAP Provides Updates on Airport Operations
  • Five Key Stocks Capturing Investor Interest Recently
  • Raytech Holding Limited Implements Share Consolidation Plan
  • Marex Group Investors: Important Class Action Update
  • Meta's AI Transformation Under Zuckerberg: A Bright Future Ahead
  • Cryptocurrency Markets React to Fed Chair Powell's Comments
  • LG Energy Solution's Impressive Q3 2025 Performance Highlights
  • Securities Class Action Filed Against Wildermuth Fund and Auditor
  • Fluor Corporation Shareholder Update: Class Action Lawsuit Insights
  • KBR Investors Face Class Action: Critical Deadline Approaching
  • James Hardie Investors Alert: Key Deadline Approaches Fast
  • Cytokinetics Facing Class Action - Key Information for Investors
  • Molina Healthcare Investors: Important Legal Updates and Guidance
  • TeraWulf Inc. Boosts and Prices $900 Million Convertible Notes
  • Investors Alert: Class Action Lawsuit Against WPP plc Overview
  • LG Energy Solution's Q3 2025 Financial Highlights Unveiled
  • Vista Expands XO Services in Asia to Meet Aviation Demand
  • Hollyland Empowers Young Creators with Sound Campus Initiative
  • TeraWulf Secures $900 Million for Growth Through Notes Offering
  • New Virtual Program Aims to Solve Car Seat Installation Issues
  • Jamie Dimon on Office Culture: Young Employees at Risk
  • Enhancing Sino-Korean Literary Ties Through Cultural Exchanges
  • Cohen Veterans Network Marks 5 Years of Service Expansion in Hawaii
  • Athabasca Oil Corporation's Thriving Q3 2025 Financial Snapshot
  • Athabasca Oil's Q3 2025 Report: Solid Growth Amid Market Challenges
  • Universal Music Group Partners with Udio for AI Music Innovation
  • Elevating Patient Care: Freedom Surgical Center's New Partnership
  • IQAX and CargoNPay Innovate with AI in Shipping Solutions
  • Ubiqconn Technology Showcases Innovations at Global Conference
  • Innovative Heart Valve Solutions Revealed at Leading Conference
  • ArkBio Advances Monoclonal Antibody Study to Combat RSV
  • Global Expansion of Chinese E-commerce During Singles Day
  • Biltmore's Enchanted Christmas Celebrations Through History
  • Celebrate the Magic of the Holidays at Biltmore Estate
  • Rubicon Organics Set to Share Q3 2025 Financial Results Soon
  • Envista Holdings Posts Impressive Q3 2025 Earnings Results
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site